<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://tpx.sagepub.com">
<title>Toxicologic Pathology recent issues</title>
<link>http://tpx.sagepub.com</link>
<description>Toxicologic Pathology RSS feed -- recent issues</description>
<prism:publicationName>Toxicologic Pathology</prism:publicationName>
<prism:issn>0192-6233</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/5/649?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/651?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/660?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/674?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/680?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/687?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/695?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/705?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/714?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/720?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/727?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/738?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/743?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/5/753?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/5/760?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/5/761?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/529?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/552?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/560?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/568?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/576?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/581?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/592?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/608?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/620?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/4/632?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/4/640?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/3/373?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/375?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/385?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/388?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/397?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/410?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/420?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/428?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/440?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/449?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/459?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/465?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/472?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/478?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/485?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/3/496?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/3/520?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/3/522?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/36/2/189?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/190?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/204?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/218?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/232?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/247?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/250?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/256?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/265?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/277?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/289?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/311?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/321?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/330?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/345?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/353?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/36/2/362?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://tpx.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://tpx.sagepub.com:80/icons/banner/title.gif">
<title>Toxicologic Pathology</title>
<url>http://tpx.sagepub.com:80/icons/banner/title.gif</url>
<link>http://tpx.sagepub.com</link>
</image>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/5/649?rss=1">
<title><![CDATA[Obituary]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/5/649?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Klaunig, J. E.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320993</dc:identifier>
<dc:title><![CDATA[Obituary]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>650</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>649</prism:startingPage>
<prism:section>Obituary</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/651?rss=1">
<title><![CDATA[The Comparative Pathology of the Glycosidase Inhibitors Swainsonine, Castanospermine, and Calystegines A3, B2, and C1 in Mice]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/651?rss=1</link>
<description><![CDATA[
<p>To study various polyhydroxy-alkaloid glycosidase inhibitors, 16 groups of 3 mice were dosed using osmotic minipumps with swainsonine (0, 0.1, 1, and 10 mg/kg/day), castanospermine, and calystegines A<SUB>3</SUB>, B<SUB>2</SUB>, and C<SUB>1</SUB> (1, 10, and 100 mg/kg/day). After 28 days, the mice were euthanized, necropsied, and examined using light and electron microscopy. The high-dose swainsonine&ndash;treated mice developed neurologic disease with neuro-visceral vacuolation typical of locoweed poisoning. Castanospermine- and calystegines-treated mice were clinically normal; however, high-dose castanospermine&ndash;treated mice had thyroid, renal, hepatic, and skeletal myocyte vacuolation. Histochemically, swainsonine- and castanospermine-induced vacuoles contained mannose-rich oligosaccharides. High-dose calystegine A<SUB>3</SUB>&ndash;treated mice had increased numbers of granulated cells in the hepatic sinusoids. Electron microscopy, lectin histochemistry, and immunohistochemistry suggest these are pit cells (specialized NK cells). Histochemically, the granules contain glycoproteins or oligosaccharides with abundant terminal <I>N</I>-acetylglucosamine residues. Other calystegine-treated mice were histologically normal. These findings indicate that swainsonine produced lesions similar to locoweed, castanospermine caused vacuolar changes with minor changes in glycogen metabolism, and only calystegine A<SUB>3</SUB> produced minimal hepatic changes. These also suggest that in mice calystegines and castanospermine are less toxic than swainsonine, and as rodents are relatively resistant to disease, they are poor models to study such induced storage diseases.</p>
]]></description>
<dc:creator><![CDATA[Stegelmeier, B. L., Molyneux, R. J., Asano, N., Watson, A. A., Nash, R. J.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317420</dc:identifier>
<dc:title><![CDATA[The Comparative Pathology of the Glycosidase Inhibitors Swainsonine, Castanospermine, and Calystegines A3, B2, and C1 in Mice]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>659</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>651</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/660?rss=1">
<title><![CDATA[Time- and Dose-based Gene Expression Profiles Produced by a Bile-duct-damaging Chemical, 4,4'-methylene Dianiline, in Mouse Liver in an Acute Phase]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/660?rss=1</link>
<description><![CDATA[
<p>A toxicogenomics study was performed in the mouse liver after treatment of a bile-duct&ndash;damaging chemical, 4,4'-methylene dianiline (MDA), across multiple doses and sampling times in an acute phase using the AB Expression Array System. Imprinting control region (ICR) mice were given a single oral administration of a low (10 mg/kg b.w.) or high (100 mg/kg b.w.) dose of MDA. Mice were sacrificed six, twenty-four, and seventy-two hours after treatment for serum chemistry, histopathology, and mRNA preparation from liver samples. Treatment with MDA increased liver-toxicity&ndash;related enzymes in blood and induced bile-duct cell injury, followed by regeneration. To explore potential biomarker gene profiles, the altered genes were categorized into four expression patterns depending on dose and time. Numerous functionally defined and unclassified genes in each category were up- or down-regulated throughout the period from cellular injury to the recovery phase, verified by RT-PCR. Many genes associated with liver toxicity and diseases belonged to one of these categories. The chemokine-mediated Th1 pathway was implicated in the inflammatory process. The genes associated with oxidative stress, apoptosis, and cell-cycle regulation were also dynamically responsive to MDA treatment. The Wnt/&beta;-catenin signaling pathway was likely responsible for the reconstitution process of the MDA-injured liver.</p>
]]></description>
<dc:creator><![CDATA[Kwon, S.-B., Park, J.-S., Yi, J.-Y., Hwang, J.-W., Kim, M., Lee, M.-O., Lee, B.-H., Kim, H.-L., Kim, J. H., Chung, H., Kong, G., Kang, K.-S., Yoon, B.-I.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320272</dc:identifier>
<dc:title><![CDATA[Time- and Dose-based Gene Expression Profiles Produced by a Bile-duct-damaging Chemical, 4,4'-methylene Dianiline, in Mouse Liver in an Acute Phase]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>673</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>660</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/674?rss=1">
<title><![CDATA[Ovarian Follicle Counts Using Proliferating Cell Nuclear Antigen (PCNA) and Semi-Automated Image Analysis in Rats]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/674?rss=1</link>
<description><![CDATA[
<p>Ovarian follicle counting is a method to assess ovarian toxicity in reproductive toxicity studies in rats. Although ovarian follicle counting has been traditionally performed manually on hematoxylin and eosin (H&amp;E)-stained sections, the use of immunohistochemical methods, including human cytochrome P450 1B1 (CYP1B1) and proliferating cell nuclear antigen (PCNA), have been used to enhance the visibility of the primordial and primary follicles to facilitate manual counting. In this study, serial sections from both ovaries from ten 3-month-old female Sprague Dawley rats were stained using routine H&amp;E and immunohistochemistry for PCNA. Counting of primordial and primary follicles was performed manually using these two stains and by semi-automated image analysis of PCNA-stained slides. Although manual counting of PCNA-stained slides is preferable to manual counting of H&amp;E-stained slides, manual counting involves variability between individual counters. Semi-automated image analysis of PCNA-stained slides yields an accurate and consistent count of these primordial/primary follicles and eliminates variability between individual counters.</p>
]]></description>
<dc:creator><![CDATA[Picut, C. A., Swanson, C. L., Scully, K. L., Roseman, V. C., Parker, R. F., Remick, A. K.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317428</dc:identifier>
<dc:title><![CDATA[Ovarian Follicle Counts Using Proliferating Cell Nuclear Antigen (PCNA) and Semi-Automated Image Analysis in Rats]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>679</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>674</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/680?rss=1">
<title><![CDATA[Effects of Residual Oil Fly Ash (ROFA) in Mice with Chronic Allergic Pulmonary Inflammation]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/680?rss=1</link>
<description><![CDATA[
<p>Exposure to particulate matter (PM) air pollution is associated with increased asthma morbidity. Residual oil flash ash (ROFA) is rich in water-soluble transition metals, which are involved in the pathological effects of PM. The objective of this study was to investigate the effects of intranasal administration of ROFA on pulmonary inflammation, pulmonary responsiveness, and excess mucus production in a mouse model of chronic pulmonary allergic inflammation. BALB/c mice received intraperitoneal injections of ovalbumin (OVA) solution (days 1 and 14). OVA challenges were performed on days 22, 24, 26, and 28. After the challenge, mice were intranasally instilled with ROFA. After forty-eight hours, pulmonary responsiveness was performed. Mice were sacrificed, and lungs were removed for morphometric analysis. OVA-exposed mice presented eosinophilia in the bronchovascular space (<I>p</I> &lt; .001), increased pulmonary responsiveness (<I>p</I> &lt; .001), and epithelial remodeling (<I>p</I> = .003). ROFA instillation increased pulmonary responsiveness (<I>p =</I> .004) and decreased the area of ciliated cells in the airway epithelium (<I>p =</I> .006). The combined ROFA instillation and OVA exposure induced a further increase in values of pulmonary responsiveness (<I>p =</I> .043) and a decrease in the number of ciliated cells in the airway epithelium (<I>p =</I> .017). PM exposure results in pulmonary effects that are more intense in mice with chronic allergic pulmonary inflammation.</p>
]]></description>
<dc:creator><![CDATA[Arantes-Costa, F. M., Lopes, F. D.T.Q.S., Toledo, A. C., Magliarelli-Filho, P. A., Moriya, H. T., Carvalho-Oliveira, R., Mauad, T., Saldiva, P. H. N., Martins, M. A.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317427</dc:identifier>
<dc:title><![CDATA[Effects of Residual Oil Fly Ash (ROFA) in Mice with Chronic Allergic Pulmonary Inflammation]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>686</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>680</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/687?rss=1">
<title><![CDATA[Effects of Food Restriction on Testis and Accessory Sex Glands in Maturing Rats]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/687?rss=1</link>
<description><![CDATA[
<p>Reduced food consumption and associated lower body weights may occur in subacute toxicity studies. The short-term effects of food restriction (FR) on body and reproductive organ weights, hormones, and testis histology were assessed in Sprague-Dawley rats fed 20% to 36% less (21 g feed/day) than rats fed ad libitum (AL) starting at six, eight, ten, or twelve weeks of age for two or six weeks. Body weight and relative seminal vesicle, ventral prostate, and/or epididymis weights were reduced in rats FR for two or six weeks. Degeneration of stage VII pachytene spermatocytes was seen in rats FR for six weeks when initiated at eight, ten, and twelve weeks of age. Plasma testosterone concentrations were lower in rats FR at ages six to eight weeks, eight to ten weeks, six to twelve weeks, and eight to fourteen weeks. Luteinizing hormone was not statistically different in FR rats compared with AL counterparts. Therefore, duration of lower food intake had a greater impact on spermatogenesis, whereas a younger initial age of lower food intake was more influential on testosterone levels. These interactions are important in the interpretation of subacute toxicology studies employing FR or when test articles lower food consumption relative to AL-fed rats.</p>
]]></description>
<dc:creator><![CDATA[Rehm, S., White, T. E., Zahalka, E. A., Stanislaus, D. J., Boyce, R. W., Wier, P. J.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320275</dc:identifier>
<dc:title><![CDATA[Effects of Food Restriction on Testis and Accessory Sex Glands in Maturing Rats]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>694</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>687</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/695?rss=1">
<title><![CDATA[Characterization of Age- and Gender-related Changes in the Spleen and Thymus from Control Cynomolgus Macaques Used in Toxicity Studies]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/695?rss=1</link>
<description><![CDATA[
<p>Age- and gender-related lymphoid tissue variability in control male and female monkeys of various ages (under three years; three to six years; seven to fifteen years) was characterized. Spleen and thymus organ weights, organ-to-body and organ-to-brain ratios, morphology by light microscopy, and B- and T-cell immunohistochemistry (IHC) were evaluated. Splenic weights and ratios were not significantly different between various age groups or genders, except males and females in the three-to-six-years age group, who exhibited statistically significant changes from the under-three-years age group. No differences in the number of primary follicles, secondary follicles with germinal centers, B-cell follicles, and periarterial lymphoid sheath were seen between age groups or genders, and no trends were noted in the spleen. By IHC, no differences were observed in B- and T-cell splenic densities. Several age- and gender-related changes in weights and ratios were noted in the thymus. The thymus had a trend toward increased interlobular fat infiltration with increasing age in both males and females. Thymic delineation of the cortex and medulla was significantly decreased in the seven-to-fifteen-years age group for males only. The cortex-to-medulla ratio was significantly lower only in males in the seven-to-fifteen-years age group. B- and T-cell cellular density did not change across various ages.</p>
]]></description>
<dc:creator><![CDATA[Spoor, M. S., Radi, Z. A., Dunstan, R. W.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320279</dc:identifier>
<dc:title><![CDATA[Characterization of Age- and Gender-related Changes in the Spleen and Thymus from Control Cynomolgus Macaques Used in Toxicity Studies]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>704</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>695</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/705?rss=1">
<title><![CDATA[Mid-gestation Exposure of C57BL/6 Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Postnatal Morphologic Changes in the Spleen and Liver]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/705?rss=1</link>
<description><![CDATA[
<p>Pregnant C57BL/6 mice were exposed to 5 &micro;g/kg 2,3,7,8-tetrachlorodibenzo-<I>p</I>-dioxin (TCDD) or vehicle by oral gavage between gestation days (GDs) 11 and 13. The thymus, spleen, and liver of the pups were examined histologically, and cell surface antigen expression was assessed on postnatal days (PNDs) 1, 14, 25, and 46. In addition to the expected decrease in thymic weight on PND 1, TCDD caused an increase in splenic weight on PND 14 and in hepatic weight on PNDs 14 and 25. The apoptotic index was increased and the corticomedullary border poorly defined in thymuses of TCDD-exposed mice on PND 1, but not at later endpoints. T lymphocytes were increased and B lymphocytes decreased in spleens of the TCDD-exposed mice on PND 46. TCDD-exposed mice had a nearly significant (<I>p</I> =.051) decrease in the number of splenic germinal centers on PND 46. Foci of extramedullary hematopoiesis (EMH) were increased in number in the livers of TCDD-exposed mice on PND 14, suggesting possible increased production of immune cells of unknown phenotype and function in this organ. These results suggest that late-gestation thymic architectural changes caused by TCDD resolve shortly after birth: however, abnormalities in other immunologically important areas may appear later in postnatal life.</p>
]]></description>
<dc:creator><![CDATA[Weinstein, D. A., Gogal, R. M., Mustafa, A., Prater, M. R., Holladay, S. D.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320276</dc:identifier>
<dc:title><![CDATA[Mid-gestation Exposure of C57BL/6 Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Postnatal Morphologic Changes in the Spleen and Liver]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>713</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>705</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/714?rss=1">
<title><![CDATA[Effects of Erdosteine on Acetaminophen-induced Hepatotoxicity in Rats]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/714?rss=1</link>
<description><![CDATA[
<p>We investigated the effects of erdosteine on acetaminophen (APAP)-induced hepatotoxicity in rats. Superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), AST (aspartate aminotransferase), and ALT (alanine transaminase) activities, and malonyldialdehyde (MDA) and nitric oxide levels as oxidant/antioxidant biochemical parameters were investigated with light microscopic evaluation in adult female Wistar Albino rats. APAP administration produced a decrease in hepatic SOD, CAT, and GSH-Px activities, and coadministration of erdosteine (150 and 300 mg/kg) resulted in increases in the activities. MDA and NO levels increased in the APAP group, and erdosteine treatments prevented these increases. Significant elevations in serum AST and ALT levels were observed in the APAP group, and when erdosteine and APAP were coadministered, their serum levels were close to those in the control group. Light microscopic evaluation of livers showed that there were remarkable centrilobular (zone III) hepatic necrosis and mild to moderate sinusoidal congestion in the APAP group, whereas in the erdosteine group, cellular necrosis was minimal and the hepatocytes maintained a better morphology when compared to the APAP group. Erdosteine prevented APAP-induced liver injury and toxic side effects probably through the antioxidant and radical scavenging effects of erdosteine.</p>
]]></description>
<dc:creator><![CDATA[Kuvandik, G., Duru, M., Nacar, A., Yonden, Z., Helvaci, R., Koc, A., Kozlu, T., Kaya, H., Sogut, S.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320800</dc:identifier>
<dc:title><![CDATA[Effects of Erdosteine on Acetaminophen-induced Hepatotoxicity in Rats]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>719</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>714</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/720?rss=1">
<title><![CDATA[Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/720?rss=1</link>
<description><![CDATA[
<p>The incidences of alveolar/bronchiolar adenomas and carcinomas in cumene-treated B6C3F1 mice were significantly greater than those of the control animals. We evaluated these lung neoplasms for point mutations in the K<I>-ras</I> and <I>p53</I> genes that are often mutated in humans. K<I>-ras</I> and <I>p53</I> mutations were detected by cycle sequencing of PCR-amplified DNA isolated from paraffin-embedded neoplasms. K<I>-ras</I> mutations were detected in 87% of cumene-induced lung neoplasms, and the predominant mutations were exon 1 codon 12 G to T transversions and exon 2 codon 61 A to G transitions. <I>P53</I> protein expression was detected by immunohistochemistry in 56% of cumene-induced neoplasms, and mutations were detected in 52% of neoplasms. The predominant mutations were exon 5, codon 155 G to A transitions, and codon 133 C to T transitions. No <I>p53</I> mutations and one of seven (14%) K<I>-ras</I> mutations were detected in spontaneous neoplasms. Cumene-induced lung carcinomas showed loss of heterozygosity (LOH) on chromosome 4 near the <I>p16</I> gene (13%) and on chromosome 6 near the K<I>-ras</I> gene (12%). No LOH was observed in spontaneous carcinomas or normal lung tissues examined. The pattern of mutations identified in the lung tumors suggests that DNA damage and genomic instability may be contributing factors to the mutation profile and development of lung cancer in mice exposed to cumene.</p>
]]></description>
<dc:creator><![CDATA[Hong, H.-H. L., Ton, T.-V. T., Kim, Y., Wakamatsu, N., Clayton, N. P., Chan, P.-C., Sills, R. C., Lahousse, S. A.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320280</dc:identifier>
<dc:title><![CDATA[Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>726</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>720</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/727?rss=1">
<title><![CDATA[Early Stellate Cell Activation and Veno-occlusive-disease (VOD)-like Hepatotoxicity in Dogs Treated with AR-H047108, an Imidazopyridine Proton Pump Inhibitor]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/727?rss=1</link>
<description><![CDATA[
<p>Dogs treated with AR-H047108, an imidazopyridine potassium competitive acid blocker (P-CAB), developed clinical signs of hepatic dysfunction as well as morphologically manifest hepatotoxicity in repeat-dose toxicity studies. An investigative one-month study was performed, with interim euthanasia after one and two weeks. A detailed histopathological and immunohistochemical characterization of the liver lesions was conducted, including markers for fibrosis, Kupffer cell activation, apoptosis, and endothelial injury. In addition, hepatic retinoid and procollagen 12 mRNA levels in livers of dogs treated with AR-H047108 were analyzed. The results showed an early inflammatory process in central veins and centrilobular areas, present after one week of treatment. This inflammatory reaction was paralleled by activation of stellate/Ito cells to myofibroblasts and was associated with sinusoidal and centrivenular fibrosis. The early activation of stellate cells coincided with a significant decrease in retinyl ester levels, and a significant increase in procollagen 12 mRNA levels, in the liver. At later time points (three and six months), there was marked sinusoidal fibrosis in centrilobular areas, as well as occlusion of central veins resulting from a combination of fibrosis and increased thickness of smooth muscle bundles in the vessel wall. The pattern of lesions suggests a veno-occlusive-disease (VOD)&ndash;like scenario, possibly linked to the imidazopyridine chemical structure of the compound facilitated by specific morphological features of the dog liver.</p>
]]></description>
<dc:creator><![CDATA[Berg, A.-L., Bottcher, G., Andersson, K., Carlsson, E., Lindstrom, A.-K., Huby, R., Hakansson, H., Skanberg-Wilhelmsson, I., Hellmold, H.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320802</dc:identifier>
<dc:title><![CDATA[Early Stellate Cell Activation and Veno-occlusive-disease (VOD)-like Hepatotoxicity in Dogs Treated with AR-H047108, an Imidazopyridine Proton Pump Inhibitor]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>737</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>727</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/738?rss=1">
<title><![CDATA[Malignant Myopericytoma-like Tumor in a Fischer Rat]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/738?rss=1</link>
<description><![CDATA[
<p>Myopericytoma is a perivascular tumor that has been recently described in humans, but not in laboratory rodents. The authors encountered an intra-abdominal tumor resembling human malignant myopericytoma in a Fischer rat. Grossly, the tumor was found as two brown-colored masses located in the mesentery of rectum. Microscopically, the tumor was composed of oval to spindle-shaped cells, which were arranged in sheets around numerous thin-walled branching vessels and partly showed a concentric perivascular growth pattern. Mitoses were frequently seen, and the tumor cells showed a local invasion. Immunohistochemically, the tumor cells were strongly positive for alpha-smooth muscle actin and weakly positive for vimentin and desmin. Ultrastructurally, the tumor cells had dendritic processes, actin-like thin filaments with dense bodies, basement membranes, hemidesmosomes, and micropinocytotic vesicles. These findings suggest that the most appropriate term for diagnosis of the present case could be a malignant myopericytoma.</p>
]]></description>
<dc:creator><![CDATA[Takahashi, N., Yoshida, T., Takeuchi, Y., Kuwahara, M., Nakashima, N., Chiba, Y., Harada, T.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320804</dc:identifier>
<dc:title><![CDATA[Malignant Myopericytoma-like Tumor in a Fischer Rat]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>742</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>738</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/743?rss=1">
<title><![CDATA[Gene Expression Studies Demonstrate that the K-ras/Erk MAP Kinase Signal Transduction Pathway and Other Novel Pathways Contribute to the Pathogenesis of Cumene-induced Lung Tumors]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/743?rss=1</link>
<description><![CDATA[
<p>National Toxicology Program (NTP) inhalation studies demonstrated that cumene significantly increased the incidence of alveolar/bronchiolar adenomas and carcinomas in B6C3F1 mice. Cumene or isopropylbenzene is a component of crude oil used primarily in the production of phenol and acetone. The authors performed global gene expression analysis to distinguish patterns of gene regulation between cumene-induced tumors and normal lung tissue and to look for patterns based on the presence or absence of K-<I>ras</I> and <I>p53</I> mutations in the tumors. Principal component analysis segregated the carcinomas into groups with and without K-<I>ras</I> mutations, but failed to separate the tumors based on <I>p53</I> mutation status. Expression of genes associated with the Erk MAP kinase signaling pathway was significantly altered in carcinomas with K-<I>ras</I> mutations compared to tumors without K-<I>ras</I> mutations or normal lung. Gene expression analysis also suggested that cumene-induced carcinomas with K-<I>ras</I> mutations have greater malignant potential than those without mutations. In addition, significance analysis of function and expression (SAFE) demonstrated expression changes of genes regulated by histone modification in carcinomas with K-<I>ras</I> mutations. The gene expression analysis suggested the formation of alveolar/bronchiolar carcinomas in cumene-exposed mice typically involves mutation of K-<I>ras</I>, which results in increased Erk MAP kinase signaling and modification of histones.</p>
]]></description>
<dc:creator><![CDATA[Wakamatsu, N., Collins, J. B., Parker, J. S., Tessema, M., Clayton, N. P., Ton, T.-V. T., Hong, H.-H. L., Belinsky, S., Devereux, T. R., Sills, R. C., Lahousse, S. A.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320801</dc:identifier>
<dc:title><![CDATA[Gene Expression Studies Demonstrate that the K-ras/Erk MAP Kinase Signal Transduction Pathway and Other Novel Pathways Contribute to the Pathogenesis of Cumene-induced Lung Tumors]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>752</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>743</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/5/753?rss=1">
<title><![CDATA[Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/5/753?rss=1</link>
<description><![CDATA[
<p>Although there are a few national schemes for accreditation/certification of toxicologic pathologists (e.g., in Japan and the United Kingdom), a global recognition system for bench toxicologic pathologists is missing, as are universal standards defining their core competencies. This paper summarizes basic means regarding how proficiency in toxicologic pathology is acquired, provides an overview over examinations of interest to toxicologic pathologists, and emphasizes the value of practical experience in the field. The paper then discusses basic approaches to evaluate the proficiency of toxicologic pathologists and examines potential means to recognize qualified toxicologic pathologists. With progressive globalization, it is important that the toxicologic pathology community deepens the discussion regarding a global recognition mechanism for their discipline.</p>
]]></description>
<dc:creator><![CDATA[Ettlin, R. A., Bolon, B., Pyrah, I., Konishi, Y., Black, H. E.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320281</dc:identifier>
<dc:title><![CDATA[Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>759</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>753</prism:startingPage>
<prism:section>Current Opinion</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/5/760?rss=1">
<title><![CDATA[Regulatory Forum for Toxicologic Pathology: An Update]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/5/760?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kerlin, R., Hutto, D., Silverman, L., Francke-Carroll, S., Vahle, J.]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308322009</dc:identifier>
<dc:title><![CDATA[Regulatory Forum for Toxicologic Pathology: An Update]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>760</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>760</prism:startingPage>
<prism:section>The Regulatory Forum</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/5/761?rss=1">
<title><![CDATA[Erratum]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/5/761?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-08-13</dc:date>
<dc:identifier>info:doi/10.1177/0192623308322018</dc:identifier>
<dc:title><![CDATA[Erratum]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>762</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>761</prism:startingPage>
<prism:section>Erratum</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/529?rss=1">
<title><![CDATA[A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/529?rss=1</link>
<description><![CDATA[
<p>Type 2 diabetes mellitus (TTDM) is characterized by progressive loss of glucose control through multifactorial mechanisms. The search for an understanding of TTDM has relied on animal models since the realization of the importance of the pancreas in controlling plasma glucose concentration. Rodent models of TTDM are developed to express hyperglycemia and not islet degeneration per se. Degeneration of the islets of Langerhans with &beta;-cell loss is secondary to insulin resistance and is regarded as the more important lesion. Despite this, differences between models are seen in the development and progression of islet degeneration. Assessing the differences between the models is important to appreciate the various aspects of TTDM and understand their advantages as well as their deficiencies. Relevant animal models of TTDM provide opportunities to investigate important physiological and cell biological processes that may ultimately lead to development of targeted therapies. This article reviews the importance, advantages, and limitations of rodent models of TTDM in relation to the histopathological changes that characterize islet degeneration. Pathophysiological mechanisms that contribute to islet degeneration are also discussed and are placed into the context of changes in islet histological appearances.</p>
]]></description>
<dc:creator><![CDATA[Nugent, D. A., Smith, D. M., Jones, H. B.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308318209</dc:identifier>
<dc:title><![CDATA[A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>551</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>529</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/552?rss=1">
<title><![CDATA[Spermatid Head Retention as a Marker of 2,5-Hexanedione-induced Testicular Toxicity in the Rat]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/552?rss=1</link>
<description><![CDATA[
<p>Histopathological analysis is a basic methodology for assessing testicular injury after exposure to candidate therapeutics or toxicants. One possible injury response in rat testis is the failure of step 19 spermatids to spermiate. Such spermatids are transported toward the basement membrane, where they are retained for degradation by Sertoli cells. In control rats, these retained spermatid heads (RSH) were observed at Stages IX&ndash;XII. Exposure to the Sertoli cell toxicant, 2,5-hexanedione (HD), for eighteen days at 0.08%&ndash;1.0% in drinking water resulted in a dose-dependent increase in the number of RSH at Stages IX&ndash;XII (no observed effect level [NOEL], 0.14%). To explore the dynamics of spermatid head retention, rats were treated with 0.33% or 1% HD for various durations and RSH were assessed across all stages. After 0.33% HD exposure for eighteen days, there were more RSH present in Stage IX&ndash;XII tubules compared to control. Numbers of RSH dropped back to control levels after four weeks of recovery after the eighteen-day exposure. Exposure of rats to 1% HD for eighteen days resulted in markedly elevated numbers of RSH at Stages IX&ndash;II/III. There was no evidence of other histopathological alterations. These data identify RSH as a sensitive histopathological marker of testicular toxicity for subacute HD exposure.</p>
]]></description>
<dc:creator><![CDATA[Bryant, B. H., Yamasaki, H., Sandrof, M. A., Boekelheide, K.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317426</dc:identifier>
<dc:title><![CDATA[Spermatid Head Retention as a Marker of 2,5-Hexanedione-induced Testicular Toxicity in the Rat]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>559</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>552</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/560?rss=1">
<title><![CDATA[Gene Expression Changes Following Acute Hydrogen Sulfide (H2S)-induced Nasal Respiratory Epithelial Injury]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/560?rss=1</link>
<description><![CDATA[
<p>Hydrogen sulfide (H<SUB>2</SUB>S) is a naturally occurring gas that is also associated with several industries. The potential for widespread human inhalation exposure to this toxic gas is a public health concern. The nasal epithelium is especially susceptible to H<SUB>2</SUB>S-induced pathology. Injury to and regeneration of the nasal respiratory mucosa occurred in animals with ongoing H<SUB>2</SUB>S exposure, suggesting that the regenerated respiratory epithelium under-goes an adaptive response and becomes resistant to further injury. To better understand this response, ten-week-old male Sprague-Dawley rats were exposed nose-only to either air or 200 ppm H<SUB>2</SUB>S for three hours per day for one day or five consecutive days. Nasal respiratory epithelial cells at the site of injury and regeneration were laser capture microdissected, and gene expression profiles were generated at three, six, and twenty-four hours after the initial three-hour exposure and at twenty-four hours after the fifth exposure using the Affymetrix Rat Genome 230 2.0 microarray. Gene ontology enrichment analysis showed that H<SUB>2</SUB>S exposure altered gene expression associated with a variety of biological processes, including cell cycle regulation, protein kinase regulation, and cytoskeletal organization and biogenesis. Surprisingly, our results did not show a significant change in cytochrome oxidase gene expression or bioenergetics.</p>
]]></description>
<dc:creator><![CDATA[Roberts, E. S., Thomas, R. S., Dorman, D. C.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317422</dc:identifier>
<dc:title><![CDATA[Gene Expression Changes Following Acute Hydrogen Sulfide (H2S)-induced Nasal Respiratory Epithelial Injury]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>567</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>560</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/568?rss=1">
<title><![CDATA[Pharmacological Effects of Nicotine on Norepinephrine Metabolism in Rat Brown Adipose Tissue: Relevance to Nicotinic Therapies for Smoking Cessation]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/568?rss=1</link>
<description><![CDATA[
<p>In a two-year carcinogenicity study with administration of high doses of the partial nicotinic agonist varenicline (recently approved for smoking cessation), mediastinal hibernomas occurred in three male rats. To investigate potential mechanisms for partial and full nicotinic agonists to contribute to development of hibernomas, the effects of nicotine on rat brown adipose tissue (BAT) were studied. Male and female rats were administered nicotine at doses of 0, 0.3, and 1 mg/kg subcutaneously for fourteen days. Intrathoracic (mediastinal periaortic and mediastinal perithymic) BAT and interscapular BAT were examined microscopically, and determinations of uncoupling protein-1 (UCP-1) expression and norepinephrine (NE) content were made. Additionally, NE turnover was measured in mediastinal periaortic and perithymic BAT. Nicotine (1 mg/kg) administration resulted in decreased vacuolation only in mediastinal periaortic and mediastinal perithymic BAT of males and elevated UCP-1 in mediastinal periaortic BAT of males and females. Increased NE content occurred only in mediastinal periaortic BAT of males given 0.3 and 1 mg/kg doses, whereas NE turnover was decreased in both males and females given 1 mg/kg. Together, these data demonstrate that nicotine primarily affects mediastinal BAT in male rats, consistent with the gender and location of the hibernomas observed in the two-year carcinogenicity study.</p>
]]></description>
<dc:creator><![CDATA[Brees, D. J., Elwell, M. R., Tingley, F. D., Sands, S. B., Jakowski, A. B., Shen, A. C., Cai, J. H., Finkelstein, M. B.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317424</dc:identifier>
<dc:title><![CDATA[Pharmacological Effects of Nicotine on Norepinephrine Metabolism in Rat Brown Adipose Tissue: Relevance to Nicotinic Therapies for Smoking Cessation]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>575</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>568</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/576?rss=1">
<title><![CDATA[Ursolic Acid and Oleanolic Acid Suppress Preneoplastic Lesions Induced by 1,2-Dimethylhydrazine in Rat Colon]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/576?rss=1</link>
<description><![CDATA[
<p>Ursolic acid (UA) and oleanolic acid (OA) are pentacyclic triterpenoid compounds found in plants used in the human diet and in medicinal herbs, in the form of aglycones or as the free acid. These compounds are known for their hepatoprotective, anti-inflammatory, antimicrobial, hypoglycemic, antimutagenic, antioxidant, and antifertility activities. In the present study, we evaluated the effects of UA and OA on the formation of 1,2-dimethyl-hydrazine (DMH)&ndash;induced aberrant crypt foci (ACF) in the colon of the male Wistar rat. The animals received subcutaneous (sc) injections of DMH (40 mg/kg body weight) twice a week for two weeks to induce ACF. UA, OA and a mixture of UA and OA were administered to the rats five times a week for four weeks by gavage at doses of 25 mg/kg body weight/day each, during and after DMH treatment. All animals were sacrificed in week 5 for the evaluation of ACF. The results showed a significant reduction in the frequency of ACF in the group treated with the triterpenoid compounds plus DMH when compared to those treated with DMH alone, suggesting that UA and OA suppress the formation of ACF and have a protective effect against colon carcinogenesis.</p>
]]></description>
<dc:creator><![CDATA[Furtado, R. A., Rodrigues, E. P., Araujo, F. R. R., Oliveira, W. L., Furtado, M. A., Castro, M. B., Cunha, W. R., Tavares, D. C.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317423</dc:identifier>
<dc:title><![CDATA[Ursolic Acid and Oleanolic Acid Suppress Preneoplastic Lesions Induced by 1,2-Dimethylhydrazine in Rat Colon]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>580</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>576</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/581?rss=1">
<title><![CDATA[Human Hepatocytes Can Repopulate Mouse Liver: Histopathology of the Liver in Human Hepatocyte-Transplanted Chimeric Mice and Toxicologic Responses to Acetaminophen]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/581?rss=1</link>
<description><![CDATA[
<p>A human hepatocyte-transplanted chimeric mouse has been established by transplantation of human hepatocytes to urokinase-type plasminogen activator transgenic/severe combined immunodeficiency (uPA<sup>+/+</sup><b>/</b>SCID) mice. These chimeric mice have various amounts of human hepatocytes that proliferate extensively and progressively replace mouse hepatocytes. In the chimeric liver, hepatic cords and sinusoid-like structures were observed. The human hepatocytes expressed human albumin, human cytochrome P450 enzymes, and human transporter proteins. Furthermore, electron microscopic analysis demonstrated bile canaliculi associated with human hepatocytes in the chimeric mouse livers. These results indicate that the chimeric mouse livers contain functionally intact and differentiated human hepatocytes. Additionally, the toxicologic response of hepatocytes to acetaminophen (APAP) administration was compared in normal and chimeric mouse livers. Following 1,400 mg/kg APAP, mild hepatocellular degeneration was observed in the human hepatocyte areas in the chimeric mice, compared with severe centrilobular hepatocellular necrosis in the ICR mouse livers. In conclusion, these chimeric livers contain functionally differentiated human hepatocytes, and are less susceptible to APAP toxicity, compared to ICR mice.</p>
]]></description>
<dc:creator><![CDATA[Sato, Y., Yamada, H., Iwasaki, K., Tateno, C., Yokoi, T., Yoshizato, K., Horii, I.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308318212</dc:identifier>
<dc:title><![CDATA[Human Hepatocytes Can Repopulate Mouse Liver: Histopathology of the Liver in Human Hepatocyte-Transplanted Chimeric Mice and Toxicologic Responses to Acetaminophen]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>591</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>581</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/592?rss=1">
<title><![CDATA[Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/592?rss=1</link>
<description><![CDATA[
<p>Health concerns have been raised because perfluorooctanoic acid (PFOA) is commonly found in the environment and can be detected in humans. In rodents, PFOA is a carcinogen and a developmental toxicant. PFOA is a peroxisome proliferator-activated receptor  (PPAR) activator; however, PFOA is capable of inducing heptomegaly in the PPAR-null mouse. To study the mechanism associated with PFOA toxicity, wild-type and PPAR-null mice were orally dosed for 7 days with PFOA (1 or 3 mg/kg) or the PPAR agonist Wy14,643 (50 mg/kg). Gene expression was evaluated using commercial microarrays. In wild-type mice, PFOA and Wy14,643 induced changes consistent with activation of PPAR. PFOA-treated wild-type mice deviated from Wy14,643-exposed mice with respect to genes involved in xenobiotic metabolism. In PFOA-treated null mice, changes were observed in transcripts related to fatty acid metabolism, inflammation, xenobiotic metabolism, and cell cycle regulation. Hence, a component of the PFOA response was found to be independent of PPAR. Although the signaling pathways responsible for these effects are not readily apparent, overlapping gene regulation by additional PPAR isoforms could account for changes related to fatty acid metabolism and inflammation, whereas regulation of xenobiotic metabolizing genes is suggestive of constitutive androstane receptor activation.</p>
]]></description>
<dc:creator><![CDATA[Rosen, M. B., Abbott, B. D., Wolf, D. C., Corton, J. C., Wood, C. R., Schmid, J. E., Das, K. P., Zehr, R. D., Blair, E. T., Lau, C.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308318208</dc:identifier>
<dc:title><![CDATA[Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>607</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>592</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/608?rss=1">
<title><![CDATA[Neurotoxic Effects of Zoniporide: A Selective Inhibitor of the Na+/H+ Exchanger Isoform 1]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/608?rss=1</link>
<description><![CDATA[
<p>Zoniporide, an inhibitor of the Na<sup>+</sup>-H<sup>+</sup> exchanger-1, was administered by continuous intravenous infusion to rats and dogs for up to 1 month. In 1-month studies, histological and functional changes were observed in select portions of the peripheral nervous system; however, these findings were not detected in 2-week studies at similar or higher doses. In the 1-month rat study, there was dose-dependent, minimal, focal, or multifocal nerve fiber (axonal) degeneration in the spinal cord and/or sciatic nerve. In a follow-up rat study, findings included slowing of caudal nerve conduction velocity and axonal degeneration in the spinal cord (dorsal funiculus), dorsal roots, dorsal root ganglia (DRG), radial, sciatic, and tibial nerves. In the 1-month dog study, there was impairment of the patellar reflex and associated postural reaction changes, minimal to marked proximal nerve fiber degeneration in the DRG, and minimal nerve fiber degeneration in the dorsal roots and funiculi of the spinal cord. Minimal nerve fiber degeneration of equivocal significance was noted in various peripheral nerves. Taken together, these findings were consistent with a specific effect on peripheral sensory nerve fibers. These studies demonstrated that zoniporide produces clinical, electrophysiologic, and microscopic evidence of peripheral sensory axonopathy and establishes the importance of careful preclinical evaluation of neurological function.</p>
]]></description>
<dc:creator><![CDATA[Pettersen, J. C., Chouinard, L., Kerlin, R. L., Groom, S. N., Botts, S., Arezzo, J. C., Boucher, M. A., Frazier, D. E., Buchholz, A. R.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308318215</dc:identifier>
<dc:title><![CDATA[Neurotoxic Effects of Zoniporide: A Selective Inhibitor of the Na+/H+ Exchanger Isoform 1]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>619</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>608</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/620?rss=1">
<title><![CDATA[Lung Toxicity of 16 Fine Particles on Intratracheal Instillation in a Bioassay Model Using F344 Male Rats]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/620?rss=1</link>
<description><![CDATA[
<p>We have developed a bioassay model to estimate toxicity of fine particles in the lungs at an early stage after intratracheal instillation (<cross-ref type="bib" refid="b28-0360620">Yokohira et al. 2005</cross-ref>; <cross-ref type="bib" refid="b29-0360620">Yokohira et al. 2007</cross-ref>). The present experiment was conducted to improve the model by estimating appropriate doses based on dose-dependent toxicity of instilled quartz (4 mg to 0 mg) as a positive control and assessing the impact of powdered particles without suspension (Experiment 1). In addition, examination of the toxicity of a series of particles was performed with the developed bioassay (Experiments 2A, 2B, and 2C). The materials chosen were sixteen particles, including nanoparticles and diesel powder. Histopathological and immunohistochemical analysis of bromodeoxyuridine (BrdU) incorporation and inducible nitric oxide synthase (iNOS) were performed after exposure of the lungs.</p>
<p>A dose of 2 mg quartz suspended in 0.2 mL saline was suggested to be most appropriate for sensitive detection of acute and subchronic inflammatory changes. Although some materials, including nanoparticles, demonstrated toxicity that was too strong for sensitive assessment, the ranking order could be given as follows: CuO &gt; quartz &gt; neutralized Na<SUB>2</SUB>PdCl<SUB>4</SUB> &gt; NiO &gt; hydrotalcite &gt; MnO<SUB>2</SUB> &gt; diesel &gt; titanium dioxide (in Experiment 2B) &gt; &beta;-cyclodextrin &gt; diesel standard &gt; titanium dioxide (in Experiment 2A) &gt; CaCO<SUB>3</SUB>.</p>
]]></description>
<dc:creator><![CDATA[Yokohira, M., Kuno, T., Yamakawa, K., Hosokawa, K., Matsuda, Y., Hashimoto, N., Suzuki, S., Saoo, K., Imaida, K.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308318214</dc:identifier>
<dc:title><![CDATA[Lung Toxicity of 16 Fine Particles on Intratracheal Instillation in a Bioassay Model Using F344 Male Rats]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>631</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>620</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/4/632?rss=1">
<title><![CDATA[Comparative Hepatic Effects of Perfluorooctanoic Acid and WY 14,643 in PPAR-{alpha} Knockout and Wild-type Mice]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/4/632?rss=1</link>
<description><![CDATA[
<p>Perfluorooctanoic acid (PFOA) is a chemical used in the production of fluoropolymers. Its persistence in the environment and presence in humans and wildlife has raised health concerns. Liver tumor induction by PFOA is thought to be mediated in rodents by PPAR-. A recent US EPA scientific advisory board questioned the contribution of PPAR- in PFOA-induced liver tumors. Liver response in CD-1, SV/129 wild-type (WT), and PPAR- knockout (KO) SV/129 mice was evaluated after seven daily treatments of PFOA-NH<SUB>4</SUB><sup>+</sup> (1, 3, or 10 mg/kg, p.o.) or the prototype PPAR-agonist Wyeth 14,643 (WY, 50 mg/kg). Livers were examined by light and electron microscopy. Proliferation was quantified after PCNA immunostaining. PFOA treatment induced a dose-dependent increase in hepatocyte hypertrophy and labeling index (LI) similar to WY in WT mice. Ultrastructural alterations of peroxisome proliferation were similar between WY-treated and 10 mg/kg PFOA-treated WT mice. KO mice had a dose-dependent increase in hepatocyte vacuolation but increased LI only at 10 mg PFOA/kg. WY-treated KO mice were not different from KO control. These data suggest that PPAR- is required for WY- and PFOA-induced cellular alterations in WT mouse liver. Hepatic enlargement observed in KO mice may be due to an accumulation of cytoplasmic vacuoles that contain PFOA.</p>
]]></description>
<dc:creator><![CDATA[Wolf, D. C., Moore, T., Abbott, B. D., Rosen, M. B., Das, K. P., Zehr, R. D., Lindstrom, A. B., Strynar, M. J., Lau, C.]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308318216</dc:identifier>
<dc:title><![CDATA[Comparative Hepatic Effects of Perfluorooctanoic Acid and WY 14,643 in PPAR-{alpha} Knockout and Wild-type Mice]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>639</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>632</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/4/640?rss=1">
<title><![CDATA[Erratum]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/4/640?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-08-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308320009</dc:identifier>
<dc:title><![CDATA[Erratum]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>640</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>640</prism:startingPage>
<prism:section>Erratum</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/3/373?rss=1">
<title><![CDATA[Obituary to Dr. Charles Capen]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/3/373?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317862</dc:identifier>
<dc:title><![CDATA[Obituary to Dr. Charles Capen]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>373</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>373</prism:startingPage>
<prism:section>Obituary</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/375?rss=1">
<title><![CDATA[The Female Rat Reproductive Cycle: A Practical Histological Guide to Staging]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/375?rss=1</link>
<description><![CDATA[
<p>During preclinical investigations into the safety of drugs and chemicals, many are found to interfere with reproductive function in the female rat. This interference is commonly expressed as a change in normal morphology of the reproductive tract or a disturbance in the duration of particular phases of the estrous cycle. Such alterations can be recognized only if the pathologist has knowledge of the continuously changing histological appearance of the various components of the reproductive tract during the cycle and can accurately and consistently ascribe an individual tract to a particular phase of the cycle. Unfortunately, although comprehensive reports illustrating the normal appearance of the tract during the rat estrous cycle have been available over many years, they are generally somewhat ambiguous about distinct criteria for defining the end of one stage and the beginning of another. This detail is absolutely essential to achieve a consistent approach to staging the cycle. For the toxicologic pathologist, this report illustrates a pragmatic and practical approach to staging the estrous cycle in the rat based on personal experience and a review of the literature from the last century.</p>
]]></description>
<dc:creator><![CDATA[Westwood, F. R.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315665</dc:identifier>
<dc:title><![CDATA[The Female Rat Reproductive Cycle: A Practical Histological Guide to Staging]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>384</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>375</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/385?rss=1">
<title><![CDATA[Foreign-Body Granulomas within Intramyocardial Arteries in a Transcoronary Safety Assessment in Pigs]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/385?rss=1</link>
<description><![CDATA[
<p>Foreign-body granulomas within intramyocardial arteries were detected in three domestic pigs (<I>Sus scrofa domestica</I>) in a routine transcoronary safety assessment study. The foreign bodies stained light grayish-blue by hematoxylin and eosin (H&amp;E) and were strongly birefringent by polarized light microscopy. By their morphological features, they were identified as cotton fibers. Embolization of foreign-body material into the myocardial arteries following catheter-based procedures is an unusual event, and its occurrence may lead to granulomatous foreign-body reaction and misinterpretation of histological results.</p>
]]></description>
<dc:creator><![CDATA[Ramot, Y., Amir, G., Willenz, E. P., Nyska, A.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315831</dc:identifier>
<dc:title><![CDATA[Foreign-Body Granulomas within Intramyocardial Arteries in a Transcoronary Safety Assessment in Pigs]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>387</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>385</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/388?rss=1">
<title><![CDATA[Spontaneous Occurrence of a Distinctive Renal Tubule Tumor Phenotype in Rat Carcinogenicity Studies Conducted by the National Toxicology Program]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/388?rss=1</link>
<description><![CDATA[
<p>The Toxicology Data Management System (TDMS) of the National Toxicology Program, National Institutes of Environmental Health Sciences, National Institutes of Health, was surveyed for occurrence and distribution of a distinctive renal tubule tumor type in rats. The hallmark features of this tumor included eosinophilic/amphophilic staining, large finely granular cells, and numerous vacuoles and/or minilumens. It is referred to here as the amphophilic-vacuolar (AV) variant of renal tubule tumor. Of 154 studies in which renal tubule tumors had been recorded in the standard single sections of kidney in the TDMS, there were collectively 1012 rats with renal adenomas, carcinomas, or adenocarcinomas, and of these, 100 displayed the distinctive AV morphology, representing 74 studies involving mostly the F344 rat, but also the Sprague-Dawley and Wistar strains. The AV tumors (mainly adenomas but also some carcinomas) occurred usually as solitary lesions in the affected animals. However, they were multiple and bilateral in a few cases. They were equally distributed between the sexes, did not metastasize (at least to the lung), and were not associated with chronic progressive nephropathy. The distribution of this renal tumor type was random across studies and dose groups, underscoring the likelihood that it was of spontaneous origin and not chemically induced. Accordingly, it is suggested that this distinctive renal tumor phenotype be recorded as a separate category from conventional RTT when assessing the carcinogenic potential of a test compound.</p>
]]></description>
<dc:creator><![CDATA[Hard, G. C., Seely, J. C., Kissling, G. E., Betz, L. J.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315829</dc:identifier>
<dc:title><![CDATA[Spontaneous Occurrence of a Distinctive Renal Tubule Tumor Phenotype in Rat Carcinogenicity Studies Conducted by the National Toxicology Program]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>396</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>388</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/397?rss=1">
<title><![CDATA[Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidney of Gentamicin-, Mercury-, or Chromium-Treated Rats: Relationship to Renal Distributions of iNOS and Nitrotyrosine]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/397?rss=1</link>
<description><![CDATA[
<p>Immunohistochemical studies for kidney injury molecule-1 (Kim-1), renal papillary antigen-1 (RPA-1), and renal papillary antigen-2 (RPA-2) were conducted to explore their relationship to inducible nitric oxide synthase (iNOS) and nitrotyrosine expression. Male Sprague-Dawley rats were exposed to gentamicin (100 mg/kg/day Gen, sc, for 3 days), mercury (0.25 mg Hg/kg, iv, single dose), or chromium (5 mg Cr/kg, sc, single dose) and kidney tissue was examined 24 hours or 72 hours after the last dose of the nephrotoxicant. Another group of kidneys was evaluated 24 hours after rats were administered 3 daily doses (50, 100, 150, 200, or 300 mg/kg/day) of Gen. Gen- and Cr-treated rats exhibited increased immunoreactivity of Kim-1, RPA-1, and RPA-2 largely in the S1/S2 segments and to a lesser extent in the S3 segments of the proximal tubule of the kidney, whereas Hg-treated rats showed increased immunoreactivity of Kim-1, RPA-1, and RPA-2 in the S3 segments. Up-regulation of Kim-1, RPA-1, and RPA-2 expression correlated with injured tubular epithelial cells and also correlated with immunoreactivity of iNOS and nitrotyrosine. It is possible that iNOS activation with nitrotyrosine production in injured nephron segments may be involved in the induction of Kim-1, RPA-1, and RPA-2 following exposure to nephrotoxicants.</p>
]]></description>
<dc:creator><![CDATA[Zhang, J., Brown, R. P., Shaw, M., Vaidya, V. S., Zhou, Y., Espandiari, P., Sadrieh, N., Stratmeyer, M., Keenan, J., Kilty, C. G., Bonventre, J. V., Goering, P. L.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315832</dc:identifier>
<dc:title><![CDATA[Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidney of Gentamicin-, Mercury-, or Chromium-Treated Rats: Relationship to Renal Distributions of iNOS and Nitrotyrosine]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>409</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>397</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/410?rss=1">
<title><![CDATA[Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/410?rss=1</link>
<description><![CDATA[
<p>CI-1033 (canertinib) is an irreversible inhibitor of the erbB family of transmembrane tyrosine kinase receptors, including the epidermal growth factor (EGF) receptor. Various inhibitors of the EGF receptor, including CI-1033, have resulted in cutaneous toxicity in humans as a common adverse event. In a chronic toxicity study in rats, CI-1033 produced cutaneous lesions with morphologic characteristics similar to that reported in man. Here the authors describe in detail the dermal changes observed, along with other noteworthy findings of that study. Male and female Wistar rats (15/sex/group) were administered CI-1033 for 27 weeks at 2.5, 5, or 10 mg/kg (15, 30, or 60 mg/m<sup>2</sup>, respectively) by gavage. Control animals (15/sex) received vehicle alone (aqueous 0.5% methylcellulose) in a dose volume of 5 mL/kg. Six animals/sex/dose were included for toxicokinetic evaluations. Skin lesions were the primary drug-related toxicity and occurred at &ge;2.5 mg/kg in a dose-dependent fashion. The major gross lesions were papules that evolved into crusts and scales that were first observed in weeks 1 and 3, respectively. Alopecia developed in conjunction with the papular eruptions. Skin changes were most pronounced in females, possibly due to higher drug levels. In week 13, CI-1033 plasma AUC(0&ndash;24) values were 527 to 1980 ng&middot;h/mL in males and 844 to 2920 ng&middot;h/mL in females at 2.5 to 10 mg/kg. Microscopic changes could be described as 3 patterns that affected the tail and body (haired skin). Pattern 1 consisted of epidermal changes that started as a superficial, perivascular spongiotic dermatitis with evolving epidermal hyperplasia, scale-crusts, and areas of ulceration. Areas of hyperplasia on the tail were often associated with the development of new hair follicles. Pattern 2 was characterized by a suppurative to pyogranulomatous infundibular folliculitis. Pattern 3 consisted of abnormally oriented hair follicles with malformed hair shafts that were associated with a deeper (isthmic) folliculitis; this correlated with alopecia. Elevations in bone marrow myeloid counts correlated with a peripheral leukocytosis, consistent with inflammatory changes in the dermis. In addition, hepatic cholestasis and epithelial atrophy in the gastrointestinal tract and vagina occurred at &ge;2.5 mg/kg. In conclusion, CI-1033 produced cutaneous lesions involving the epidermis and hair follicle, and the morphologic characteristics were similar to that reported in clinical studies with various inhibitors of the EGF receptor. These changes are consistent with pharmacologic inhibition of the EGF receptor in these tissues and demonstrate that the rat can serve as an animal model for investigating the mechanisms for this toxicity.</p>
]]></description>
<dc:creator><![CDATA[Brown, A. P., Dunstan, R. W., Courtney, C. L., Criswell, K. A., Graziano, M. J.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315827</dc:identifier>
<dc:title><![CDATA[Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>419</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>410</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/420?rss=1">
<title><![CDATA[Relationship between GST Yp Induction and Hepatocyte Proliferation in Rats Treated with Phase II Drug Metabolizing Enzyme Inducers]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/420?rss=1</link>
<description><![CDATA[
<p>Butylated hydroxyanisole (BHA) and 1,2-bis(2-pyridyl)ethylene (2PY-e) are phase II drug metabolizing enzyme inducers which cause hepatomegaly without hepatocyte hypertrophy and induce glutathione <I>S</I>-transferase Yp (GST Yp, pi-class GST), which is known as a tumor marker. To evaluate the relationship between GST Yp induction and hepatocyte proliferation, male F344/DuCrj rats were treated with BHA, 2PY-e, or phenobarbital (PB) for three or seven days. All three chemicals caused increases in liver weight after three and seven days. Immunohistochemical examinations revealed that BHA and 2PY-e induced GST Yp in the hepatocytes of the periportal and centrilobular areas at three and seven days, respectively, whereas PB did not. Significant increases in the BrdU labeling indices were found in the livers of rats in each of the three-day treatment groups, but the labeling index of rat livers treated with BHA was decreased to the control level at seven days, although the high labeling indices of 2PY-e and PB persisted at seven days. Double immunostaining confirmed that BrdU-positive nuclei corresponded to GST Yp-positive hepatocytes in both BHA and 2PY-e treated rats. These results suggest that the GST Yp induction caused by BHA or 2PY-e has some kind of relationship with hepatocyte proliferation.</p>
]]></description>
<dc:creator><![CDATA[Makino, T., Ishikawa, K., Igarashi, I., Yamoto, T., Manabe, S., Nakayama, H.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315359</dc:identifier>
<dc:title><![CDATA[Relationship between GST Yp Induction and Hepatocyte Proliferation in Rats Treated with Phase II Drug Metabolizing Enzyme Inducers]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>427</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>420</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/428?rss=1">
<title><![CDATA[Summary of Chemically Induced Pulmonary Lesions in the National Toxicology Program (NTP) Toxicology and Carcinogenesis Studies]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/428?rss=1</link>
<description><![CDATA[
<p>The lung is the second most common target site of neoplasia of chemicals tested by the National Toxicology Program (NTP). Of all peer-reviewed NTP studies to date (N = 545), a total of sixty-four chemicals in sixty-six reports produced significant site-specific neoplasia in the lungs of rats and/or mice. Of the studies associated with lung tumor induction, approximately 35% were inhalation and 35% were gavage studies, with dosed-feed, dosed-water, topical, intraperitoneal, or in utero routes of chemical administration accounting for 18%, 6%, 3%, 1%, and 1% of the studies, respectively. The most commonly induced lung tumors were alveolar/bronchiolar (A/B) adenoma and/or carcinoma for both species. The most frequently observed nonneoplastic lesions included hyperplasia and inflammation in both species. The liver was the most common primary site of origin of metastatic lesions to the lungs of mice; however, skin was most often the primary site of origin of metastatic lesions to the lungs of rats. In summary, A/B adenoma and carcinoma were the most frequently diagnosed chemically induced tumors in the lungs of both rats and mice in the NTP toxicology and carcinogenesis bioassays, and hyperplasia and inflammation were the most common nonneoplastic changes observed.</p>
]]></description>
<dc:creator><![CDATA[Dixon, D., Herbert, R. A., Kissling, G. E., Brix, A. E., Miller, R. A., Maronpot, R. R.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315360</dc:identifier>
<dc:title><![CDATA[Summary of Chemically Induced Pulmonary Lesions in the National Toxicology Program (NTP) Toxicology and Carcinogenesis Studies]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>439</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>428</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/440?rss=1">
<title><![CDATA[Changes in Clara Cell 10 kDa Protein (CC10)-positive Cell Distribution in Acute Lung Injury Following Repeated Lipopolysaccharide Challenge in the Rat]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/440?rss=1</link>
<description><![CDATA[
<p>Clara cell 10 kDa protein (CC10) is the major secretory protein of Clara cells and is thought to play a protective role in the lung owing to its anti-inflammatory properties. There is little information on the anatomical distribution of CC10-positive cells in rat lung following lipopolysaccharide (LPS) challenge. We have determined the expression of CC10 along the tracheobronchial tree in saline-treated and LPS-treated rats. Saline-treated rats showed sporadic CC10 staining in central airways and abundant staining in bronchioles. In transitional airways, most cells were positive except for squamous cells. Following LPS challenge, there was a reduction in staining in the upper airways but little change within bronchioles. Squamous epithelia within the transitional airways now showed positive staining. These cells also co-stained for pancytokeratin and appeared to co-localize with surfactant D- and Ki67-positive cells, indicating the presence of a dedifferentiated cell type with both epithelial and pneumocyte phenotypes. These data show that diffuse inflammatory injury results in generalized loss of CC10 in central airways. Conversely, the transitional airways showed evidence of a dedifferentiated population of squamous cells that now stained for CC10. We hypothesize that this is an attempt by peripheral lung to maintain alveolar sac integrity during an inflammatory episode.</p>
]]></description>
<dc:creator><![CDATA[Bolton, S. J., Pinnion, K., Marshall, C. V., Wilson, E., Barker, J. E., Oreffo, V., Foster, M. L.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315357</dc:identifier>
<dc:title><![CDATA[Changes in Clara Cell 10 kDa Protein (CC10)-positive Cell Distribution in Acute Lung Injury Following Repeated Lipopolysaccharide Challenge in the Rat]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>448</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>440</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/449?rss=1">
<title><![CDATA[Acute Effects of Microcystins MC-LR and MC-RR on Acid and Alkaline Phosphatase Activities and Pathological Changes in Intraperitoneally Exposed Tilapia Fish (Oreochromis sp.)]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/449?rss=1</link>
<description><![CDATA[
<p>Microcystins (MC) are frequently present in cyanobacterial blooms in rivers and lakes, increasing the risk of toxicity to both animals and humans. There more than eighty reported microcystins, and the present study was undertaken to determine whether MC-LR and MC-RR can induce different enzyme alterations and histopathological changes in tilapia fish (<I>Oreochromis sp.</I>) exposed to a single intraperitoneal (i.p.) injection of the pure standards (MC-LR and MC-RR) at a dose of 500 &micro;g/kg; the tilapia fish were then observed for seven days. The two MC variants caused significant changes in the activities of acid and alkaline phosphatases (ACP and ALP) in vital organs, showing a different response pattern. The livers and kidneys of fish injected with MC-LR were particularly affected. MC-RR induced a very pronounced increase of ACP in the kidney and a significant increase of ALP in the liver. Both MC variants caused pathological lesions in hepatic tissues, such as megalocytosis, necrotic process, and microvesicular steatosis, particularly in fish treated with MC-LR, and degenerative renal changes, glomerulopathy, were more severe in tilapias exposed to MC-RR. In addition, both microcystins also caused significant myopathy in the heart. In contrast, the gills did not show any change in enzyme activity or histopathological injury.</p>
]]></description>
<dc:creator><![CDATA[Atencio, L., Moreno, I., Prieto, A. I., Moyano, R., Molina, A. M., Camean, A. M.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315356</dc:identifier>
<dc:title><![CDATA[Acute Effects of Microcystins MC-LR and MC-RR on Acid and Alkaline Phosphatase Activities and Pathological Changes in Intraperitoneally Exposed Tilapia Fish (Oreochromis sp.)]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>458</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>449</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/459?rss=1">
<title><![CDATA[A New Medium-term Rat Colorectal Bioassay Applying Neoplastic Lesions as End Points for Detection of Carcinogenesis Modifiers Effects with Weak or Controversial Modifiers]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/459?rss=1</link>
<description><![CDATA[
<p>We have established a two-stage, medium-term rat colorectal carcinogenesis model featuring induction of neoplastic lesions within ten weeks. In the present study, we examined the ability of this model to detect weak modifiers. F344 male rats were given three subcutaneous (sc) injections of 1,2-dimethyl-hydrazine (DMH, 40 mg/kg b.w.) in one week followed by drinking water containing 1% dextran sodium sulfate (DSS) for a second week. One week after this regimen, basal diet alone, or diets containing 10% perilla oil, 10% corn oil, 10% dextrin, or 0.1% indole-3-carbinol (I3C) were supplied. The perilla oil and corn oil groups did not show significant differences in the numbers of aberrant crypt foci (ACF) and incidences or multiplicity of proliferative lesions as compared to the controls at either time point. In the dextrin group, the total number of ACF at week ten was significantly increased. With I3C, the total number of ACF and incidence and multiplicities of adenocarcinomas at week ten and the incidence of invasive tumors at week twenty were significantly increased. These data essentially correspond with earlier reported results, except in the vegetable oil cases. Thus, the system is suitable for detection of colorectal carcinogenesis modifiers with advantages over previous models using ACF alone as end points.</p>
]]></description>
<dc:creator><![CDATA[Cho, Y.-M., Imai, T., Ota, Y., Hasumura, M., Takami, S., Hirose, M., Nishikawa, A.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315358</dc:identifier>
<dc:title><![CDATA[A New Medium-term Rat Colorectal Bioassay Applying Neoplastic Lesions as End Points for Detection of Carcinogenesis Modifiers Effects with Weak or Controversial Modifiers]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>464</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>459</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/465?rss=1">
<title><![CDATA[Spontaneous and Age-Related Testicular Findings in Beagle Dogs]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/465?rss=1</link>
<description><![CDATA[
<p>This study was conducted to characterize spontaneous testicular and epididymal microscopic findings in eighty control beagle dogs from toxicity studies. Hypospermatogenesis, characterized by randomly scattered missing spermatids and/or spermatocytes within seminiferous tubules, was observed in 75% of dogs six to seven months of age and declined to fewer than 10% in dogs over eleven months of age. Atrophy/hypoplasia of seminiferous tubules, characterized by subcapsular triangular clusters of tubules containing no germ cells, was observed in 25 to 40% of dogs under twelve months old, decreasing with age to 14 to 17% in dogs twelve to thirty-six months old. Retained spermatids, multinucleate giant cells, intracytoplasmic vacuoles (presumably in Sertoli cells), and swollen spermatocytes were common findings of minimal severity. Six- and seven-month-old dogs had lower testicular weights, less filling of the epididymal tails with sperm, and a two-fold higher incidence of abnormal epididymal content compared to dogs more than eight months of age. Most male beagles were histologically sexually mature by eight to nine months of age. This study confirms published reports that dogs at least ten months of age at necropsy usually are adequate for routine microscopic evaluation of the testes. If evaluation of spermatogenesis is critical, the incidental findings can be minimized by using males over twelve months of age.</p>
]]></description>
<dc:creator><![CDATA[Goedken, M. J., Kerlin, R. L., Morton, D.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315670</dc:identifier>
<dc:title><![CDATA[Spontaneous and Age-Related Testicular Findings in Beagle Dogs]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>471</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>465</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/472?rss=1">
<title><![CDATA[Evidence of a Threshold-Effect for 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline Liver Carcinogenicity in F344/DuCrj Rats]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/472?rss=1</link>
<description><![CDATA[
<p>To estimate potential human risk of exposure to a food-derived, genotoxic hepatocarcinogen, 2-amino-3,8-dimethylimidazo[4,5-<I>f</I>]quinoxaline (MeIQx), a 2-year carcinogenicity test was conducted using male F344 rats administered MeIQx-containing diet at doses of 0 (control), 0.001, 1, and 100 ppm. The lowest dose 0.001 ppm was established as equivalent to the daily intake of this carcinogen in humans (0.2 to 2.6 &micro;g/man/day). Significant decreases of survival rate and body weight gain were observed in rats treated with 100 ppm MeIQx. Histopathological examination revealed significant induction of hepatocellular carcinomas, adenomas, and development of glutathione <I>S</I>-transferase placental form&ndash;positive foci with MeIQx at 100 ppm. Moreover, the incidences of Zymbal&rsquo;s glands carcinoma, mammary fibroadenoma, and subcutaneous fibroma were found significantly increased in a 100 ppm MeIQx group. However, no significant induction of altered preneoplastic hepatocellular foci was observed in 0.001 and 1 ppm groups as compared to the controls. 8-Hydroxy-2&rsquo;-deoxyguanosine levels in the rat liver DNA of the 100 ppm-treated group were not elevated, but MeIQx-DNA adduct formation increased as compared with the 1 ppm case, albeit without significance. No significant induction of any other neoplastic lesions related to the carcinogen administration was found in MeIQx-administered groups except for 100 ppm. These results imply that 1 ppm may be a no-effect level for MeIQx carcinogenesis.</p>
]]></description>
<dc:creator><![CDATA[Murai, T., Mori, S., Kang, J. S., Morimura, K., Wanibuchi, H., Totsuka, Y., Fukushima, S.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315671</dc:identifier>
<dc:title><![CDATA[Evidence of a Threshold-Effect for 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline Liver Carcinogenicity in F344/DuCrj Rats]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>477</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>472</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/478?rss=1">
<title><![CDATA[Neuroexcitatory Targets in the Female Reproductive System of the Nonhuman Primate (Macaca fascicularis)]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/478?rss=1</link>
<description><![CDATA[
<p>Glutamate receptors (GluRs) have been implicated in brain function and pathology. Their presence in peripheral tissues suggests a vital role in the pathophysiology of various organ systems. In earlier studies, the authors reported the differential distribution of ionotropic and metabotropic GluRs in neural and nonneural peripheral tissues of the rat. In this study, they investigated the presence and the localization of the GluRs in the reproductive organs of <I>Macaca fascicularis</I>. The data illustrate the presence of the GluR 2/3, metabotropic glutamate receptor 2/3, kainate 2, and N-methyl-D-aspartate receptor 1 (NMDAR 1). These are localized in the different structures of the ovaries, uterine cervix, myometrium, endometrium, and inflammatory cells. Smooth muscle of the myometrium and arterioles showed strong immunolabeling with anti-GluR 2/3 and, to a lesser intensity, with the other ionotropic glutamate receptor antibodies. NMDAR 1 showed the most widespread staining in all the structures. Mast cells showed strong immunolabeling with the anti-NMDA antibody. The demonstration and the differential expression of GluRs in the female reproductive system of nonhuman primate experimental models provide first evidence suggesting excitatory signaling in these tissues.</p>
]]></description>
<dc:creator><![CDATA[Gill, S., Barker, M., Pulido, O.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315663</dc:identifier>
<dc:title><![CDATA[Neuroexcitatory Targets in the Female Reproductive System of the Nonhuman Primate (Macaca fascicularis)]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>484</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>478</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/485?rss=1">
<title><![CDATA[Trans-Species Comparison of PPAR and RXR Expression by Rat and Human Urothelial Tissues]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/485?rss=1</link>
<description><![CDATA[
<p>Because some investigational peroxisome proliferator-activated receptors (PPAR) agonists cause tumors in the lower urinary tract of rats, we compared normal human and rat urothelium in terms of PPAR and retinoid X receptor (RXR) expression and proliferation-associated phenotypes. In situ, few human but most rat urothelial cells were Ki67 positive, indicating fundamental differences in cell cycle control. Rat and human urothelia expressed all 3 PPAR and the RXR and RXR&beta; isoforms in a predominantly nuclear localization, indicating that they may be biologically active. However, immunolocalization differences were observed between species. First, whereas PPAR and PPAR&beta;/ were expressed throughout the human bladder or ureteric urothelium, in the rat urothelium PPAR was primarily, and PPAR&beta;/ exclusively, restricted to superficial cells. Second, RXR&beta; was restricted to intermediate and superficial layers of the human urothelium but tended to be absent from the rat superficial cells. Third, PPAR expression was present throughout the urothelia of both species but was most intense in the superficial human urothelium. Species differences were also observed in the expression of PPAR and RXR isoforms between cultured rat and human urothelial cells and in the smooth muscle. Our findings highlight the unique coexpression of multiple PPAR and RXR isoforms by urothelium and suggest that species differences in PPAR function between rat and human urothelia may be explored in an in vitro setting.</p>
]]></description>
<dc:creator><![CDATA[Chopra, B., Hinley, J., Oleksiewicz, M. B., Southgate, J.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315672</dc:identifier>
<dc:title><![CDATA[Trans-Species Comparison of PPAR and RXR Expression by Rat and Human Urothelial Tissues]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>495</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>485</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/3/496?rss=1">
<title><![CDATA[Transcriptional Profiling of Laser Capture Microdissected Rat Arterial Elements: Fenoldopam-induced Vascular Toxicity as a Model System]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/3/496?rss=1</link>
<description><![CDATA[
<p>Transcriptional profiling of specific elements of vasculature from animal models of vascular toxicity is an approach to gain insight into molecular mechanisms of vascular injury. Feasibility of using laser capture microdissection (LCM) to evaluate differential gene expression in selected elements of mesenteric arteries (MA) from untreated rats and rats given a single vasotoxic dose of 100 mg/kg Fenoldopam and euthanized 1 or 4 hours postdose was assessed. Regions of MA (endothelial cells [EC] and vascular smooth muscle cells [VSMC]) were selectively microdissected from optimal-cutting-temperature (O.C.T.)-embedded-frozen tissue sections. RNA was isolated, linearly amplified (LA), and hybridized to Affymetrix GeneChips&reg;. Enrichment for specific vascular elements was evident by unique gene-expression profiles. Statistical analysis indicated that Fenoldopam treatment resulted in differential expression of 333 versus 458 genes in EC and 371 versus 618 genes in VSMC at the 1-hour or 4-hour time point, respectively. Analysis of regulated EC and VSMC genes common to both time points identified several gene functions or pathways affected by treatment. Several genes were identified in EC and/or VSMC that have not been previously linked to vascular structure or function. These data indicate that tissue&ndash;element-enrichment by LCM in conjunction with LA and GeneChip analysis offers a refined approach for assessment of injury-mediated transcriptome changes in distinct elements of the vasculature.</p>
]]></description>
<dc:creator><![CDATA[Dalmas, D. A., Scicchitano, M. S., Chen, Y., Kane, J., Mirabile, R., Schwartz, L. W., Thomas, H. C., Boyce, R. W.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623307311400</dc:identifier>
<dc:title><![CDATA[Transcriptional Profiling of Laser Capture Microdissected Rat Arterial Elements: Fenoldopam-induced Vascular Toxicity as a Model System]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>519</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>496</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/3/520?rss=1">
<title><![CDATA[Response to Letter of Vahle et al.]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/3/520?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Jolette, J., Wilker, C. E., Fox, J.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315836</dc:identifier>
<dc:title><![CDATA[Response to Letter of Vahle et al.]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>521</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>520</prism:startingPage>
<prism:section>Letters to the Editor</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/3/522?rss=1">
<title><![CDATA[On the Toxicity of GDNF]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/3/522?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hutchinson, M.]]></dc:creator>
<dc:date>2008-06-03</dc:date>
<dc:identifier>info:doi/10.1177/0192623308315835</dc:identifier>
<dc:title><![CDATA[On the Toxicity of GDNF]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>522</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>522</prism:startingPage>
<prism:section>Letters to the Editor</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/36/2/189?rss=1">
<title><![CDATA[STP Student Speaker Award 2006]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/36/2/189?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Foster, J. R.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623308317895</dc:identifier>
<dc:title><![CDATA[STP Student Speaker Award 2006]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>189</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>189</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/190?rss=1">
<title><![CDATA[Chronic Microcystin Exposure Induces Hepatocyte Proliferation with Increased Expression of Mitotic and Cyclin-associated Genes in P53-deficient Mice]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/190?rss=1</link>
<description><![CDATA[
<p>Homozygous p53 deficient knockout mice were used to assess the role of p53 in tumor promotion by the protein phosphatase inhibitor and hepatic tumor promoter microcystin-LR (MCLR). More than 50% of human cancers bear mutations in the p53 gene, and in particular, p53 tumor suppressor gene mutations have been shown to play a major role in hepatocarcinogenesis. Trp53 homozygous (inactivated p53) and age-matched wild-type control mice were assigned to vehicle or MCLR-treated groups. MCLR or saline was administered daily for up to 28 days. RNA from the 28-day study was hybridized onto Mouse Genome GeneChip arrays. Selected RNA from 28 days and earlier time points was also processed for quantitative polymerase chain reaction (PCR). Livers from the 28-day, Trp53-deficient, MCLR group displayed greater hyperplastic and dysplastic changes morphologically and increases in Ki-67 and phosphohistone H3 (mitotic marker) immunoreactivity. Gene-expression analysis revealed significant increases in expression of cell-cycle regulation and cellular proliferation genes in the MCLR-treated, p53-deficient mutant mice compared to controls. These data suggest that regulation of the cell cycle by p53 is important in preventing the proliferative response associated with chronic, sublethal microcystin exposure, and therefore, conclude that p53 plays an important role in MCLR-induced tumor promotion.</p>
]]></description>
<dc:creator><![CDATA[Clark, S. P., Ryan, T. P., Searfoss, G. H., Davis, M. A., Hooser, S. B.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307311406</dc:identifier>
<dc:title><![CDATA[Chronic Microcystin Exposure Induces Hepatocyte Proliferation with Increased Expression of Mitotic and Cyclin-associated Genes in P53-deficient Mice]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>203</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>190</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/204?rss=1">
<title><![CDATA[Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/204?rss=1</link>
<description><![CDATA[
<p>Recent voluntary withdrawal of the ergoline-derivative Alzheimers&rsquo; drug Pergolide (Permax) resulting from demonstrated risk of cardiac valve injury illustrates the increased importance of valve injury in pharmaceutical toxicology. Following the 2001 landmark discovery of cardiac valve injury associated with the widely prescribed anti-obesity drug combination fenfluramine-phentermine, and subsequent withdrawal, the need to understand and assess cardiac valve biology and pathology both preclinically and clinically has been accentuated. Unique aspects of the developmental biology, anatomy, and physiology of cardiac valves compared to main cardiac tissue have been discovered, and key elements of the pathophysiology of various valvular injury mechanisms have been described. Although general clinical cardiac valvular disease in humans has been well characterized, animal modeling of valvular injury has proved to be difficult and undersubscribed. Additionally, both the preclinical, pharmaceutical, toxicologic assessment of valvular injury and the understanding of species-comparative valvular pathology have been limited. As discoveries and awareness grows, the purpose of this paper is to review the structure and function of cardiac valves, mechanisms, and outcomes of the common acquired human cardiac valve diseases, including those that are drug-related; to summarize comparative laboratory animal valvular pathology; and to review the literature of contemporary animal models of valvular injury.</p>
]]></description>
<dc:creator><![CDATA[Donnelly, K. B.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307312707</dc:identifier>
<dc:title><![CDATA[Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>217</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>204</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/218?rss=1">
<title><![CDATA[Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a {gamma}-dominant PPAR {alpha}/{gamma} Agonist: Lack of Evidence for Urolithiasis as an Inciting Event]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/218?rss=1</link>
<description><![CDATA[
<p>Naveglitazar, a -dominant peroxisome proliferator-activated receptor (PPAR) / dual agonist, was tested for carcinogenicity in F344 rats in a 2-year study. Changes in urine composition and urothelial morphology were characterized in a companion 18-month investigative study. A significant increase in neoplasms of the bladder occurred only in females of the high-dose group (14/60) in the carcinogenicity study. Trends toward increased cell proliferation in the urothelium were noted in both sexes at all time points evaluated in the 18-month study. Group means for urothelial mitogenesis were increased statistically significantly only in high-dose females at 12 and 18 months. Urothelial hyperplasia occurred in high-dose females at 18 months. Morphologic changes in the urothelium at earlier time points were limited to hypertrophy and decreased immunolabeling of the superficial cells for cytokeratin 20 (a marker of terminal differentiation in urothelial cells) in both males and females. No treatment-related changes in urinary parameters, including urinary sediments, were associated with the occurrence of urothelial proliferation. Urinary pH was unaffected by treatment in both males and females, but expected diurnal changes were demonstrated. Collectively, these data indicate that naveglitazar was associated with hypertrophic and proliferative effects on the urothelium, but a link with changes in urinary parameters was not demonstrated.</p>
]]></description>
<dc:creator><![CDATA[Long, G. G., Reynolds, V. L., Lopez-Martinez, A., Ryan, T. E., White, S. L., Eldridge, S. R.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307311757</dc:identifier>
<dc:title><![CDATA[Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a {gamma}-dominant PPAR {alpha}/{gamma} Agonist: Lack of Evidence for Urolithiasis as an Inciting Event]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>231</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>218</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/232?rss=1">
<title><![CDATA[Toxicity, DNA Binding, and Cell Proliferation in Male F344 Rats following Short-term Gavage Exposures to Trans-2-Hexenal]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/232?rss=1</link>
<description><![CDATA[
<p>Hexenal is a genotoxic compound to which humans are exposed daily through the consumption of foods and beverages. The present studies were conducted to examine the relationships between the dose-responses of <I>trans</I>-2-hexenal-induced toxicity, DNA adduct formation, and cell proliferation. Male F344 rats were exposed by gavage to single doses of up to 500 mg/kg and killed 1, 2, or 4 days after dosing or were exposed to repeat doses of up to 100 mg/kg once daily for 5 days or 5 days per week for 4 weeks and killed 1 day after the end of the dosing period. Histologically, the primary observations were necroulcerative lesions, inflammation, and hyperplasia in the forestomach and inflammation in the glandular stomach. Hexenal-derived DNA adduct formation and cell proliferation were induced in the forestomach at doses of hexenal that also induced gastric toxicity; DNA adducts were not observed in the glandular stomach. These findings suggest that the toxicity of hexenal was limited to the site of contact (stomach) and that the observed DNA adduct formation and cell proliferation occurred in the setting of severe tissue damage.</p>
]]></description>
<dc:creator><![CDATA[Stout, M. D., Bodes, E., Schoonhoven, R., Upton, P. B., Travlos, G. S., Swenberg, J. A.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307311758</dc:identifier>
<dc:title><![CDATA[Toxicity, DNA Binding, and Cell Proliferation in Male F344 Rats following Short-term Gavage Exposures to Trans-2-Hexenal]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>246</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>232</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/247?rss=1">
<title><![CDATA[Spontaneous Leiomyosarcoma Arising from the Ethmoid Turbinate of a Rat]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/247?rss=1</link>
<description><![CDATA[
<p>Spontaneous leiomyosarcoma arising from the left ethmoid turbinate was observed microscopically in an 83-week-old male F344 rat. The tumor cells showed smooth-muscle differentiation with prominent nuclear pleomorphism and a small number of mitotic figures. The tumor cells were also immunohistochemically positive for smooth-muscle actin. The tumor protruded slightly into the nasal cavity and invaded the surrounding tissues. The present article is the first case of spontaneous leiomyosarcoma in the rat nasal cavity.</p>
]]></description>
<dc:creator><![CDATA[Kasahara, K., Yamakawa, S., Nagatani, M., Tsurukame, M., Tamura, K.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307312692</dc:identifier>
<dc:title><![CDATA[Spontaneous Leiomyosarcoma Arising from the Ethmoid Turbinate of a Rat]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>249</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>247</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/250?rss=1">
<title><![CDATA[Evaluation of the Cynomolgus Monkey Stomach: Recommendations for Standard Sampling Procedures in Nonclinical Safety Studies]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/250?rss=1</link>
<description><![CDATA[
<p>The cynomolgus macaque is the most commonly used nonhuman primate in nonclinical toxicity testing, but the macroscopic and microscopic anatomy of the stomach in the cynomolgus macaque is poorly described. To develop a reliable sampling method for histologic evaluation of the cynomolgus macaque stomach in regulatory toxicity studies, the stomachs of control animals were prospectively evaluated using an extensive sectioning pattern. The stomach of the cynomolgus macaque differs from that described for the human stomach and has a prominent fundus that lacks parietal cells. A description of the macroscopic and microscopic anatomy is presented along with a recommended sectioning pattern for nonclinical toxicity studies and discussion of species differences. A thorough understanding of normal anatomy and species comparisons are critical to interpretation of potential toxicity findings and assessment of risk in humans.</p>
]]></description>
<dc:creator><![CDATA[Vidal, J. D., Mirabile, R. C., Thomas, H. C.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307312700</dc:identifier>
<dc:title><![CDATA[Evaluation of the Cynomolgus Monkey Stomach: Recommendations for Standard Sampling Procedures in Nonclinical Safety Studies]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>255</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>250</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/256?rss=1">
<title><![CDATA[Temporal Gene Expression Profiling Indicates Early Up-regulation of Interleukin-6 in Isoproterenol-induced Myocardial Necrosis in Rat]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/256?rss=1</link>
<description><![CDATA[
<p>Gene expression was evaluated in the myocardium of male Wistar rats after a single subcutaneous administration of 0.5 mg of isoproterenol, a &beta;-adrenergic agonist that causes acute tachycardia with subsequent myocardial necrosis. Histology of the heart, clinical chemistry, and hematology were evaluated at 9 time points (0.5 hours to 14 days postinjection). Myocardial gene expression was evaluated at 4 time points (1 hour to 3 days). Contraction bands and loss of cross-striation were identified on phosphotungstic acid-hematoxylin-stained sections 0.5 hours postdosing. Plasma troponin I elevation was detected at 0.5 hours, peaked at 3 hours, and returned to baseline values at 3 days postdosing. Interleukin 6 (Il6) expression spiked at 1 to 3 hours and was followed by a short-lived, time-dependent dysregulation of its downstream targets. Concurrently and consistent with the kinetics of the histologic findings, many pathways indicative of necrosis/apoptosis (p38 mitogen-activated protein kinase [MAPK] signaling, NF-B signaling) and adaptation to hypertension (PPAR signaling) were overrepresented at 3 hours. The 1-day and 3-day time points indicated an adaptive response, with down-regulation of the fatty acid metabolism pathway, up-regulation of the fetal gene program, and superimposed inflammation and repair at 3 days. These results suggest early involvement of Il6 in isoproterenol-induced myocardial necrosis and emphasize the value of early time points in transcriptomic studies.</p>
]]></description>
<dc:creator><![CDATA[Mikaelian, I., Coluccio, D., Morgan, K. T., Johnson, T., Ryan, A. L., Rasmussen, E., Nicklaus, R., Kanwal, C., Hilton, H., Frank, K., Fritzky, L., Wheeldon, E. B.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307312696</dc:identifier>
<dc:title><![CDATA[Temporal Gene Expression Profiling Indicates Early Up-regulation of Interleukin-6 in Isoproterenol-induced Myocardial Necrosis in Rat]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>264</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>256</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/265?rss=1">
<title><![CDATA[Whole Mount Enzyme Histochemistry as a Rapid Screen at Necropsy for Expression of {beta}-Galactosidase (LacZ)-Bearing Transgenes: Considerations for Separating Specific LacZ Activity from Nonspecific (Endogenous) Galactosidase Activity]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/265?rss=1</link>
<description><![CDATA[
<p>Whole mount enzyme histochemistry to localize <I>lacZ</I>-bearing transgenes (lacZ-WMH) also detects endogenous &beta;-galactosidases. The experiments reported here evaluated lacZ-WMH as a potential tool for transgene expression analysis during high-throughput rodent necropsies. A lacZ-WMH survey of organs from adult, wild-type, male and female mice (C57BL/6, FVB/N) and female rats (Sprague-Dawley) performed at the optimal pH (&ge; 7.0) for bacterial lacZ yielded intense endogenous staining in the gonads, kidney, male accessory sex organs, salivary glands, submucosal glands in the duodenum, and thyroid. Substantial staining occurred in the adrenal cortex, lymph nodes, and linings of the gastrointestinal tract, the urinary bladder and uterus, and (for rat only) in the adenohypophysis, bone marrow, thymus, and trigeminal ganglia. Endogenous galactosidases were distributed similarly in sections of flash-frozen organs used for slide-based lacZ histochemistry (lacZ-SBH) at pH &le; 5.0 (optimal for eukaryotic enzymes). Cerebral neurons were labeled only by lacZ-SBH. At pH 7.4, endogenous but not specific lacZ activity was abolished for lacZ-SBH, while endogenous activity was not halted without reducing specific activity for lacZ-WMH. These data demonstrate that lacZ-WMH is feasible during rodent necropsies for many but not all organs if species-, strain-, and sex-specific divergence in endogenous galactosidase activity is considered and special fixation (3% paraformaldehyde for 3 hours at 4&deg;C) is used.</p>
]]></description>
<dc:creator><![CDATA[Bolon, B.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307312693</dc:identifier>
<dc:title><![CDATA[Whole Mount Enzyme Histochemistry as a Rapid Screen at Necropsy for Expression of {beta}-Galactosidase (LacZ)-Bearing Transgenes: Considerations for Separating Specific LacZ Activity from Nonspecific (Endogenous) Galactosidase Activity]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>276</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>265</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/277?rss=1">
<title><![CDATA[Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/277?rss=1</link>
<description><![CDATA[
<p>The present study was undertaken to characterize myocardial lesions in the rat induced by low doses of isoproterenol (Iso) and to correlate lesion severity with release of cardiac troponin T (cTnT) and changes in myocyte iNOS expression. Two types of cardiac injury patterns were observed. A Type I response, noted 3 or 6 hours postdosing with 8, 16, 32, or 64 &micro;g/kg Iso, included potential reversible myocardial alterations associated with slight increases in serum cTnT (&lt; 0.3 ng/mL) and a slight reduction in myocyte cTnT immunoreactivity. The second type of response noted 3, 6, 12, 24 or 48 hours postdosing with 125, 250, or 500 &micro;g/kg Iso consisted of irreversible myocyte alterations, together with significant increases in serum cTnT (3&ndash;14 ng/mL) and a marked reduction of cTnT immunoreactivity. By 48 hours the hearts of rats dosed with 125&ndash;500 &micro;g/kg Iso had developed interstitial fibrosis, and serum cTnT had declined to near control levels (0.06&ndash;0.18 ng/mL). Increases in iNOS immunoreactivity correlated with the lesion severity. These findings suggest that low doses of Iso exert complex effects on the myocardium and that the generation of NO through increased expression of iNOS could be an important factor in the pathogenesis of myocyte injury.</p>
]]></description>
<dc:creator><![CDATA[Zhang, J., Knapton, A., Lipshultz, S. E., Weaver, J. L., Herman, E. H.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307313010</dc:identifier>
<dc:title><![CDATA[Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>278</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>277</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/289?rss=1">
<title><![CDATA[Long-term Air Pollution Exposure Is Associated with Neuroinflammation, an Altered Innate Immune Response, Disruption of the Blood-Brain Barrier, Ultrafine Particulate Deposition, and Accumulation of Amyloid {beta}-42 and {alpha}-Synuclein in Children and Young Adults]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/289?rss=1</link>
<description><![CDATA[
<p>Air pollution is a serious environmental problem. We investigated whether residency in cities with high air pollution is associated with neuroinflammation/neurodegeneration in healthy children and young adults who died suddenly. We measured mRNA cyclooxygenase-2, interleukin-1&beta;, and CD14 in target brain regions from low (n = 12) or highly exposed residents (n = 35) aged 25.1 &plusmn; 1.5 years. Upregulation of cyclooxygenase-2, interleukin-1&beta;, and CD14 in olfactory bulb, frontal cortex, substantia nigrae and vagus nerves; disruption of the blood-brain barrier; endothelial activation, oxidative stress, and inflammatory cell trafficking were seen in highly exposed subjects. Amyloid &beta;42 (A&beta;42) immunoreactivity was observed in 58.8% of apolipoprotein E (APOE) 3/3 &lt; 25 y, and 100% of the APOE 4 subjects, whereas -synuclein was seen in 23.5% of &lt; 25 y subjects. Particulate material (PM) was seen in olfactory bulb neurons, and PM &lt; 100 nm were observed in intraluminal erythrocytes from lung, frontal, and trigeminal ganglia capillaries.</p>
<p>Exposure to air pollution causes neuroinflammation, an altered brain innate immune response, and accumulation of A&beta;42 and -synuclein starting in childhood. Exposure to air pollution should be considered a risk factor for Alzheimer&rsquo;s and Parkinson&rsquo;s diseases, and carriers of the APOE 4 allele could have a higher risk of developing Alzheimer&rsquo;s disease if they reside in a polluted environment.</p>
]]></description>
<dc:creator><![CDATA[Calderon-Garciduenas, L., Solt, A. C., Henriquez-Roldan, C., Torres-Jardon, R., Nuse, B., Herritt, L., Villarreal-Calderon, R., Osnaya, N., Stone, I., Garcia, R., Brooks, D. M., Gonzalez-Maciel, A., Reynoso-Robles, R., Delgado-Chavez, R., Reed, W.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307313011</dc:identifier>
<dc:title><![CDATA[Long-term Air Pollution Exposure Is Associated with Neuroinflammation, an Altered Innate Immune Response, Disruption of the Blood-Brain Barrier, Ultrafine Particulate Deposition, and Accumulation of Amyloid {beta}-42 and {alpha}-Synuclein in Children and Young Adults]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>36</prism:volume>
<prism:endingPage>310</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:startingPage>289</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/36/2/311?rss=1">
<title><![CDATA[Smad Signaling in the Rat Model of Monocrotaline Pulmonary Hypertension]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/36/2/311?rss=1</link>
<description><![CDATA[
<p>Mutations in the bone morphogenetic protein receptor type II (BMPrII) gene have been implicated in the development of familial pulmonary artery hypertension (PAH). The function of BMP signal transduction within the pulmonary vasculature and the role BMPrII mutations have in the development of PAH are incompletely understood. We used the monocrotaline (MCT) model of PAH to examine alterations in Smad signal transduction pathways in vivo. Lungs harvested from Sprague-Dawley rats treated with a single 60-mg/kg intraperitoneal (IP) injection of MCT were compared to saline-treated controls 2 weeks following treatment. Smad 4 was localized by immunohistochemistry to endothelial nuclei of the intra-acinar vessels undergoing remodeling. Smad 4, common to both BMP and transforming growth factor &beta; (TGF&beta;) signaling, and BMP-specific Smad 1 were significantly decreased in western blot from whole lungs of treated animals, while no change was found for TGF&beta;-specific Smad 2. MCT-treated rats also had increased expression of phosphorylated Smad 1 (P-Smad 1) but not phosphorylated Smad 2 (P-Smad 2). There was a decrease in the expression of the full BMPrII protein but not its short form variant in MCT-treated rat lungs. The type I receptor Alk1 had increased expression. Collectively, our data indicate that vascular remodeling in the MCT model is associated with alterations in BMP receptors and persistent endothelial Smad 1 signaling.</p>
]]></description>
<dc:creator><![CDATA[Ramos, M. F., Lame, M. W., Segall, H. J., Wilson, D. W.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1177/0192623307311402</dc:identifier>
<dc:title><![CDATA[Smad Signaling in the Rat Model of Monocrotaline Pulmonary Hypertension]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>2</pris